Evidence map›Paper›PMID 36874365›Full record

ArticleOpen medicine (Warsaw, Poland)2023

Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies.

Natalia Treder, Alina Plenis, Olga Maliszewska, Natalia Kaczmarczyk, Ilona Olędzka, Piotr Kowalski, Tomasz Bączek, Ewa Bień, Małgorzata Anna Krawczyk, Anna Roszkowska

Abstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Use of Sirolimus, an mTOR Inhibitor, to Treat Sarcoidosis in Multiple Systems.Journal of cardiovascular translational research · 2025
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Natalia TrederDepartment of Analytical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Alina PlenisDepartment of Analytical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Olga MaliszewskaDepartment of Analytical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Natalia KaczmarczykDepartment of Pharmaceutical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Ilona OlędzkaDepartment of Pharmaceutical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Piotr KowalskiDepartment of Pharmaceutical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Tomasz BączekDepartment of Pharmaceutical Chemistry, Medical University of Gdansk, Gdansk, Poland.
Ewa BieńDepartment of Pediatrics, Hematology and Oncology, Medical University Gdansk, Gdansk, Poland.
Małgorzata Anna KrawczykDepartment of Pediatrics, Hematology and Oncology, Medical University Gdansk, Gdansk, Poland.
Anna RoszkowskaDepartment of Pharmaceutical Chemistry, Medical University of Gdansk, Gdansk, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years,

Indexed as

DLLMELC-MS/MSSIRtherapeutic drug monitoringwhole blood samples

Identifiers

PMID36874365
PMCPMC9982740

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.